» Articles » PMID: 21373275

Nosocomial Infections and Multidrug-resistant Organisms in Germany: Epidemiological Data from KISS (the Hospital Infection Surveillance System)

Overview
Date 2011 Mar 5
PMID 21373275
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Background: More than 800 hospitals and 586 intensive care units (ICUs) in Germany currently participate in a nationwide surveillance system for nosocomial infections (Krankenhaus-Infektions-Surveillance-System, KISS), which collects data on the frequency of nosocomial infections and pathogens and on the appearance of pathogens of special epidemiological importance.

Methods: Data were collected from ICUs regarding lower respiratory tract infections, primary sepsis, and urinary tract infections and on the temporal relation of these types of infection to the use of specific medical devices (invasive ventilation, central venous catheters, and urinary catheters). On the basis of these data, device-associated infection rates (number of infection per 1000 device days) were calculated for different types of ICUs. KISS also collected data on all ICU patients colonized or infected with selected multidrug-resistant organisms (MDRO) and on all hospitalized patients with methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile-associated diarrhea (CDAD).

Results: Device-associated infection rates ranged from 0.9 to 9.6 per 1000 device-days, depending on the type of infection and the type of ICU. An extrapolation from these figures yields an estimate of 57 900 ICU-acquired infections occurring in Germany each year. The most common MDRO in ICU patients is MRSA. The frequency of MRSA has remained stable in recent years, but that of other MDROs among ICU patients is rising. Hospitalized patients are twice as likely to acquire CDAD as they are to acquire MRSA.

Conclusion: Nosocomial infections are common in the ICU. The percentage of ICU patients with MDRO is low, but rising. Future preventive strategies must address this development.

Citing Articles

Biofilm formation and drug susceptibility of biofilm spp. clinically isolated from nasopharyngeal cancer patients in Vietnam.

Nguyen B, Tran L, Vo T, Nguyen-Ha A, Le M, Nguyen P Iran J Microbiol. 2024; 16(5):698-707.

PMID: 39534299 PMC: 11551658. DOI: 10.18502/ijm.v16i5.16806.


Synthesis, Characterization, and Evaluation of the Antimicrobial and Anticancer Activities of Zinc Oxide and Aluminum-Doped Zinc Oxide Nanocomposites.

Asif M, Fakhar-E-Alam M, Tahir M, Jamil F, Sardar H, Rehman J Pharmaceuticals (Basel). 2024; 17(9).

PMID: 39338378 PMC: 11435269. DOI: 10.3390/ph17091216.


Knowledge, attitude and practice of healthcare workers on infection prevention and control in Ethiopia: A systematic review and meta-analysis.

Wubneh C, Mekonnen B, Alemu T, Techane M, Assimamaw N, Belay G PLoS One. 2024; 19(9):e0308348.

PMID: 39236020 PMC: 11376544. DOI: 10.1371/journal.pone.0308348.


Surfactants' Interplay with Biofilm Development in and .

Aonofriesei F Pharmaceutics. 2024; 16(5).

PMID: 38794319 PMC: 11125353. DOI: 10.3390/pharmaceutics16050657.


Individual and institutional predisposing factors of MRSA surgical site infection and outcomes-a retrospective case-control-study in 14 European high-volume surgical centres.

Rutz J, Naendrup J, Bruns C, Classen A, Salmanton-Garcia J, Seifert H JAC Antimicrob Resist. 2024; 6(2):dlae046.

PMID: 38577701 PMC: 10993902. DOI: 10.1093/jacamr/dlae046.


References
1.
Richards M, Edwards J, Culver D, Gaynes R . Nosocomial infections in pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Pediatrics. 1999; 103(4):e39. DOI: 10.1542/peds.103.4.e39. View

2.
Harbarth S, Sax H, Gastmeier P . The preventable proportion of nosocomial infections: an overview of published reports. J Hosp Infect. 2003; 54(4):258-66; quiz 321. DOI: 10.1016/s0195-6701(03)00150-6. View

3.
Zuschneid I, Geffers C, Sohr D, Kohlhase C, Schumacher M, Ruden H . Validation of surveillance in the intensive care unit component of the German nosocomial infections surveillance system. Infect Control Hosp Epidemiol. 2007; 28(4):496-9. DOI: 10.1086/512631. View

4.
Rello J, Torres A . Microbial causes of ventilator-associated pneumonia. Semin Respir Infect. 1996; 11(1):24-31. View

5.
Gastmeier P, Schwab F, Sohr D, Behnke M, Geffers C . Reproducibility of the surveillance effect to decrease nosocomial infection rates. Infect Control Hosp Epidemiol. 2009; 30(10):993-9. DOI: 10.1086/605720. View